Delmas, P D <br/><br/>
Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  Jul 2008 
 - 1039-45 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0937-941X 
<br/><br/><label>Standard No.: </label>10.1007/s00198-007-0531-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Administration, Oral<br/>Aged<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Etidronic Acid--administration & dosage<br/>Female<br/>Femur Neck<br/>Humans<br/>Lumbar Vertebrae<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Pelvic Bones<br/>Risedronic Acid<br/>Treatment Outcome